DTDespoina Theotoka

Despoina Theotoka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Despoina Theotoka has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Morgagnian Cataract: Clinical Features, Surgical Management, and Outcomes

    by Sujin Kang, Ryan T. Wallace, Steven J. Gedde, Caroline M. Borie, Zubair A. Ansari, Luis E. Vazquez, Anat Galor, Basil K. Williams, Sonia H. Yoo, Despoina Theotoka

  • Open Access

    Intraocular Lens-Associated Uveitis-Glaucoma-Hyphema Syndrome

    by Sujin Kang, Despoina Theotoka, Dena Ballouz, Justin A. Chen, Angela Y. Zhu, William E. Smiddy, Steven J. Gedde, Elena Bitrian, Justin H. Townsend, Harry W. Flynn, et al.

  • Open Access

    A Tear-Based Approach for Rapid Identification of Bacterial Pathogens in Corneal Ulcers Using Nanopore Sequencing

    by Mark Dibbs, Mitchelle Matesva, Despoina Theotoka, Christina Jayaraj, Beruk Metiku, Patrick Demkowicz, Jacob S. Heng, Yvonne Wang, Christine Y. Bakhoum, Jessica Chow, et al.

    Purpose Corneal ulcers pose a significant threat to vision, with the need for prompt and precise pathogen identification being critical to effective treatment. This study assesses the efficacy of using next-generation portable sequencing (Nanopore Technology) to detect and identify bacterial pathogens directly from tear samples, providing a non-invasive alternative to traditional corneal scraping and culture, which are limited by high false-negative rates. Design Prospective observational study. Participants Ten participants diagnosed with corneal ulcers. Methods Tear samples were collected from the ocular surface using Schirmer strips. Corneal scrapings and cultures were performed as medically indicated. The 16S rRNA gene was amplified directly from the tear samples using polymerase chain reaction (PCR), and Nanopore sequencing was used for bacterial species identification and taxonomic classification. Comparative analysis was conducted to evaluate the concordance between Nanopore sequencing results and traditional culture methods. Main Outcome Measures Comparison of bacterial species detected via Nanopore sequencing with those identified through traditional culture methods. Results Bacterial DNA was identified in 8 of the 10 samples analyzed using the tear-based sequencing method. Notably, Nanopore sequencing accurately identified the causative bacteria in all 4 samples that exhibited bacterial growth on culture. Additionally, it detected bacterial pathogens in 2 of the 4 ulcers that did not show bacterial growth on culture. In 2 cases where cultures could not be obtained due to the small size of the ulcer, tear sequencing successfully identified bacterial species, highlighting potentially overlooked pathogens in corneal ulcers. Conclusions PCR amplification of 16S RNA directly from tears followed by Nanopore sequencing is an effective, non-invasive method to identify bacterial pathogens in corneal ulcers, offering non-inferior results to traditional culture methods. This technique not only allows for the detection of traditionally hard-to-culture organisms, providing immediate diagnostic value to guide treatment, but also enhances our understanding of the microbiological landscape of corneal ulcers, thereby informing more effective treatment strategies.

  • Open Access

    Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak

    by Brittany Perzia, Despoina Theotoka, Katie Li, Emily Moss, Mitchelle Matesva, Mohsain Gill, Mercy Kibe, Jessica Chow, Stephanie Green


  • Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment

    by Despoina Theotoka, Zhiping Liu, Sarah Wall, Anat Galor, Ghada J. Al Bayyat, William Feuer, Wang Jianhua, Carol L. Karp


  • The use of high resolution optical coherence tomography (HR-OCT) in the diagnosis of ocular surface masqueraders

    by Despoina Theotoka, Sarah Wall, Anat Galor, Wathanee Sripawadkul, Rayan Abou Khzam, Vincent Tang, Dubovy L. Sander, Carol L. Karp


  • A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain

    by Harrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, Christian Paba, Abdullah A. Cheema, Ryan S. Kim, Anat Galor

    Despite being a common presenting symptom to eye-care clinics, many ophthalmologists have difficulty diagnosing and managing ocular surface pain. The purpose of this review is to discuss potential causes of ocular surface pain, focusing on both nociceptive and neuropathic aetiologies. Specifically, we outline an approach to the diagnosis of ocular surface pain and focus on various management strategies, providing supporting evidence on the efficacy of various treatments.


  • Open Access

    Total Tear IgE Levels Correlate with Allergenic and Irritating Environmental Exposures in Individuals with Dry Eye

    by Harrison Dermer, Despoina Theotoka, Charity J. Lee, Priyanka Chhadva, Abigail S. Hackam, Anat Galor, Naresh Kumar

    Dry eye (DE) and allergic conjunctivitis may present similarly, and it remains unclear whether some individuals have an underlying allergic component to their DE. To better understand this relationship, we performed a cross-sectional study in 75 individuals with DE symptoms and/or signs. Immunoglobulin E (IgE) levels in tear samples were quantified and home environmental exposures assessed via standardized survey. Tears were collected by Schirmer strip, and total tear IgE levels were quantified using enzyme-linked immunosorbent assay (ELISA). Data were analyzed using descriptive statistics and linear and logistic regressions. The main outcome measures were total tear IgE levels and their association with environmental exposures. The mean age of the subjects was 66.2 ± 7.8 years. Sixty-two individuals had dry eye symptoms (Dry Eye Questionnaire-5 ≥ 6), and 75 had one or more signs of DE. Detectable total tear IgE levels were observed in 76% of subjects, and 17.3% had high levels (>1 ng/mL). Individuals with exposure to pet(s) (odds ratio (OR) 11.5, p = 0.002) and smoke (OR 38.6, p = 0.008) at home were more likely to have high IgE levels compared to those not exposed. Individuals with tears collected during spring or summer were 3.9 times (p = 0.028) more likely to have high IgE compared to those sampled at other times of year. Subjects born in the US were 3.45 times (p = 0.010) more likely to have high IgE compared to individuals born outside the US. To conclude, a majority of individuals with DE symptoms and/or signs had detectable IgE levels in their tears. High tear IgE levels were correlated with allergy season and exposures in the home linked with allergy.


  • Open Access

    Diseases Linked to Polypharmacy in Elderly Patients

    by Ioannis Vrettos, Panagiota Voukelatou, Apostolos Katsoras, Despoina Theotoka, Andreas Kalliakmanis

    Introduction. Polypharmacy in several cases is deemed necessary and elderly patients are prone to this phenomenon. The objective of this study was to identify the prevalence and the predictors of polypharmacy among consecutively unplanned admissions of patients aged ≥65 years. Patients and Methods. In 310 patients (51% women), mean age 80.24 years (95% CI 79.35–81.10), demographic characteristics, medical history, medications, and cause of admission were recorded. Parametric tests and multiple logistic regression analysis were applied to identify the factors that have significant association with polypharmacy. Results. 53.5% of patients belonged to polypharmacy group. In multivariate analysis the independent predictors of polypharmacy were arterial hypertension (p=0.003, OR = 2.708, and 95% CI 1.400–5.238), coronary artery disease (p=0.001, OR = 8.274, and 95% CI 3.161–21.656), heart failure (p=0.030, OR = 4.042, and 95% CI 1.145–14.270), atrial fibrillation (p=0.031, OR = 2.477, and 95% CI 1.086–5.648), diabetes mellitus (p=0.010, OR = 2.390, and 95% CI 1.232–4.636), dementia (p=0.001, OR = 4.637, and 95% CI 1.876–11.464), and COPD (p=0.022, OR = 3.626, and 95% CI 1.208–10.891). Conclusions. Polypharmacy mainly was linked to cardiovascular diseases. If deprescribing is not feasible, physicians must oversee those patients in order to recognise early, possible drug reactions.